4Wealth Advisors’s AbbVie ABBV Stock Holding History

4Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$384K	Sell	1,459 -1,797	-55%	-$461K	0.27%	84
2026 Q2	$828K	Sell	3,256 -5	-0.2%	-$1.08K	0.64%	49
2026 Q1	$695K	Buy	3,261 +136	+4%	+$30.2K	0.59%	52
2025 Q4	$714K	Sell	3,125 -124	-4%	-$28.2K	0.61%	56
2025 Q3	$752K	Buy	3,249 +265	+9%	+$54K	0.67%	43
2025 Q2	$554K	Sell	2,984 -13	-0.4%	-$2.42K	0.56%	62
2025 Q1	$628K	Sell	2,997 -332	-10%	-$64.5K	0.68%	42
2024 Q4	$592K	Buy	+3,329	New	+$612K	0.59%	53

Other funds holding ABBV

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

4Wealth Advisors's ABBV Position: Q3 2026 in Review

4Wealth Advisors reduced its AbbVie (ABBV) stake by 55% in Q3 2026, selling an estimated $461K and leaving 1,459 shares worth $384K. The position accounts for 0.27% of the portfolio, ranked #84.

4Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. The position peaked at $828K in Q2 2026. 2,418 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

4Wealth Advisors held 1,459 shares of AbbVie worth $384K as of Q3 2026.
4Wealth Advisors sold 1,797 AbbVie shares in Q3 2026, an estimated $461K.
AbbVie made up 0.27% of 4Wealth Advisors's portfolio in Q3 2026, its #84 holding.
4Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
4Wealth Advisors's AbbVie position peaked at $828K in Q2 2026.
2,418 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on 4Wealth Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.